|
RBM33 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.78800000051017E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56161999999016E-05 |
| Normal-vs-Stage2 |
7.841600E-04 |
| Normal-vs-Stage3 |
1.00109999956466E-07 |
| Normal-vs-Stage4 |
4.356400E-03 |
| Stage1-vs-Stage2 |
9.271400E-01 |
| Stage1-vs-Stage3 |
1.501640E-01 |
| Stage1-vs-Stage4 |
5.234200E-01 |
| Stage2-vs-Stage3 |
2.780600E-01 |
| Stage2-vs-Stage4 |
6.844600E-01 |
| Stage3-vs-Stage4 |
1.137640E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.2397999999969E-06 |
| Normal-vs-AfricanAmerican |
4.543600E-02 |
| Normal-vs-Asian |
2.867900E-02 |
| Caucasian-vs-AfricanAmerican |
3.038800E-01 |
| Caucasian-vs-Asian |
9.123900E-02 |
| AfricanAmerican-vs-Asian |
8.519800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.992800E-04 |
| Normal-vs-Female |
3.1903999997418E-07 |
| Male-vs-Female |
1.752230E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.52213999999873E-05 |
| Normal-vs-Age(41-60Yrs) |
1.038380E-04 |
| Normal-vs-Age(61-80Yrs) |
8.98769999979621E-07 |
| Normal-vs-Age(81-100Yrs) |
1.028380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.095400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.361000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.925800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.904200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.365800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.183600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.83230000014601E-07 |
| Classical-VS-Follicular |
2.715600E-02 |
| Classical-VS-Other |
5.720200E-01 |
| Classical-VS-Normal |
2.166400E-04 |
| Tall-VS-Follicular |
8.282800E-03 |
| Tall-VS-Other |
8.383600E-02 |
| Tall-VS-Normal |
8.43429770469584E-11 |
| Follicular-VS-Other |
8.671200E-01 |
| Follicular-VS-Normal |
1.56982999999222E-05 |
| Other-VS-Normal |
4.190000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.60099999999297E-06 |
| Normal-vs-N1 |
1.596630E-03 |
| N0-vs-N1 |
7.827000E-01 |
|
|
